Cargando…
A multidisciplinary approach with immunotherapies for advanced hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is a highly aggressive disease that is usually diagnosed at an advanced stage. Advanced HCC has limited treatment options and often has a poor prognosis. For the past decade, tyrosine kinase inhibitors have been the only treatments approved for advanced HCC that have s...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Korean Liver Cancer Association
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565553/ https://www.ncbi.nlm.nih.gov/pubmed/37743048 http://dx.doi.org/10.17998/jlc.2023.09.04 |